Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ICU

SeaStar Medical Holding Corp

Oct 04 • 10:00AM ET

4.28

Dollar change -0.01
Percentage change -0.23	%

Healthcare • Biotechnology • USA • NASD

Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-20.20	Insider Own	8.56%	Shs Outstand	4.19M	Perf Week	0.00%
Market Cap	17.93M	Forward P/E	-	EPS next Y	-2.57	Insider Trans	0.28%	Shs Float	3.83M	Perf Month	-14.06%
Income	-33.23M	PEG	-	EPS next Q	-1.13	Inst Own	4.12%	Short Float	3.09%	Perf Quarter	-62.91%
Sales	0.00M	P/S	-	EPS this Y	73.59%	Inst Trans	-2.24%	Short Ratio	0.78	Perf Half Y	-75.46%
Book/sh	-2.14	P/B	-	EPS next Y	67.83%	ROA	-1145.80%	Short Interest	0.12M	Perf Year	-71.04%
Cash/sh	0.28	P/C	15.20	EPS next 5Y	-	ROE	-103.15%	52W Range	3.25 - 42.92	Perf YTD	-61.33%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-90.03%	Beta	-1.11
Dividend TTM	-	Quick Ratio	0.24	Sales past 5Y	0.00%	Gross Margin	-	52W Low	31.69%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	0.24	EPS Y/Y TTM	70.53%	Oper. Margin	0.00%	RSI (14)	38.95	Volatility	6.97% 8.14%
Employees	12	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	18.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	83.30%	Payout	-	Rel Volume	0.22	Prev Close	4.29
Sales Surprise	-	EPS Surprise	26.95%	Sales Q/Q	-	Earnings	Aug 13 AMC	Avg Volume	150.91K	Price	4.28
SMA20	-9.50%	SMA50	-27.80%	SMA200	-64.51%	Trades		Volume	4,064	Change	-0.23%

Sep-25-24 08:30AM	SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial (GlobeNewswire) -6.26%
Sep-05-24 08:00AM	SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference (GlobeNewswire) -5.14%
Sep-04-24 08:30AM	SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt (GlobeNewswire) +7.36%
Aug-23-24 05:45AM	SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU (PR Newswire)
Aug-13-24 04:38PM	SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire) -16.51% -17.46%
12:38PM	Loading…
Aug-08-24 12:38PM	SeaStar Medical Holding Corporation Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights ICU (GlobeNewswire)
Jul-26-24 09:00AM	Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE Therapy at Cincinnati Children's (GlobeNewswire) +11.53%
Jul-23-24 08:30AM	First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's FDA-Approved QUELIMMUNE Therapeutic Device (GlobeNewswire) +9.78%
Jul-17-24 09:00AM	Nuwellis Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children's (GlobeNewswire)
Jul-16-24 08:30AM	CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical's Selective Cytopheretic Device Pivotal Trial (GlobeNewswire) +6.71%
Jul-12-24 08:30AM	SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner (GlobeNewswire) +12.27%
Jul-11-24 04:05PM	SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -5.08%
Jul-10-24 09:00AM	SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -37.92%
Jul-03-24 08:30AM	SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device (GlobeNewswire)
Jun-12-24 07:00AM	Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now (GlobeNewswire) -10.53%
08:30AM	Loading…
Jun-11-24 08:30AM	SeaStar Medical's Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology (GlobeNewswire)
07:00AM	Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now (GlobeNewswire)
Jun-10-24 08:30AM	SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company (GlobeNewswire) -23.25%
Jun-07-24 08:30AM	Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation (GlobeNewswire)
Jun-06-24 04:05PM	SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024 (GlobeNewswire) -39.41%
08:30AM	SeaStar Medical Announces 25-for-1 Reverse Stock Split (GlobeNewswire)
May-22-24 08:30AM	Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical's Selective Cytopheretic Device Who Achieved Transplant Eligibility (GlobeNewswire)
May-20-24 10:53AM	ICU Stock Earnings: SeaStar Medical Holding Misses EPS for Q1 2024 (InvestorPlace) +6.14%
May-14-24 04:05PM	SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire) -11.87%
Apr-30-24 08:30AM	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure (GlobeNewswire) -6.61%
Apr-17-24 04:00PM	SeaStar Medical Reports 2023 Financial Results and Provides a Business Update (GlobeNewswire) -22.79%
Apr-16-24 11:52PM	ICU Stock Earnings: SeaStar Medical Holding Misses EPS for Q4 2023 (InvestorPlace) +7.20%
Apr-11-24 08:30AM	SeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference (GlobeNewswire)
Apr-02-24 11:26AM	LM Funding America, Inc. (NASDAQ:LMFA) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.95%
Mar-27-24 08:30AM	SeaStar Medical to Restate Financials, Sets Business Update Call for April 17 (GlobeNewswire)
08:30AM	Loading…
Mar-12-24 08:30AM	SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients (GlobeNewswire) +11.00%
Mar-11-24 04:05PM	SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024 (GlobeNewswire) +11.64%
Feb-27-24 08:30AM	Manuscript Discussing the Benefit of SeaStar Medical's Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure (GlobeNewswire) -7.85%
Feb-22-24 07:58AM	Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune (GlobeNewswire) -23.45%
07:53AM	FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney Injury (GlobeNewswire)
Feb-01-24 08:30AM	SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology (GlobeNewswire)
Jan-26-24 08:05AM	SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) -5.59%
Jan-11-24 04:05PM	SeaStar Medical Appoints David A. Green as Chief Financial Officer (GlobeNewswire) -8.41%
Jan-09-24 08:30AM	SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications (GlobeNewswire)
Dec-28-23 08:30AM	SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire) -5.93%
Dec-13-23 08:30AM	SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts (GlobeNewswire)
Nov-14-23 04:04PM	SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire) -6.39%
Oct-31-23 08:00AM	Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device (GlobeNewswire) -17.93%
Oct-30-23 09:00PM	Discover the Next Nokia: 3 Penny Stocks With Big Potential (InvestorPlace)
08:00AM	FDA Issues Approvable Letter for SeaStar Medical's Selective Cytopheretic Device for Pediatric Patients (GlobeNewswire)
Oct-18-23 08:30AM	FDA Grants SeaStar Medical's Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome (GlobeNewswire) +70.05%
Oct-05-23 08:30AM	SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023 (GlobeNewswire)
Oct-03-23 04:05PM	SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption (GlobeNewswire) +41.49%
Oct-02-23 07:08PM	3 Micro-Cap Stocks Set to Explode Higher (InvestorPlace) +57.95%
Sep-29-23 08:30AM	FDA Grants Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome (GlobeNewswire) +41.18%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire) -10.58%
Aug-29-23 08:00AM	Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medicals Selective Cytopheretic Device Published in the Journal Blood Purification (GlobeNewswire)
Aug-22-23 08:00AM	SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time (GlobeNewswire) +5.23%
Aug-14-23 04:35PM	SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire) -5.06%
Jun-30-23 08:00AM	SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients (GlobeNewswire)
Jun-20-23 04:05PM	First Patient Enrolled in SeaStar Medicals Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire) -5.30%
Jun-14-23 08:00AM	SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023 (GlobeNewswire)
May-15-23 04:45PM	SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire) +8.52% -23.13%
May-10-23 08:00AM	SeaStar Medical to Present at the JMP Securities Life Sciences Conference on May 16, 2023 (GlobeNewswire) -39.69%
May-09-23 04:05PM	SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device (GlobeNewswire)
Apr-19-23 08:00AM	SeaStar Medical Announces Activation of First Clinical Site in Pivotal Trial with Selective Cytopheretic Device in Critically Ill Adults with Acute Kidney Injury (GlobeNewswire)
Mar-30-23 07:23PM	SeaStar Medical Reports 2022 Financial Results and Provides a Business Update (GlobeNewswire) -7.46%
Mar-21-23 07:00AM	Presenting on the Emerging Growth Conference on March 22 Register Now (GlobeNewswire)
Mar-16-23 08:00AM	SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement (GlobeNewswire) -9.72%
Mar-15-23 04:05PM	SeaStar Medical to Present at the Emerging Growth Virtual Conference on March 22, 2023 (GlobeNewswire) -7.30%
Feb-24-23 08:05AM	SeaStar Medicals Selective Cytopheretic Device to be Featured at the 5th Chronic Kidney Disease Drug Development Summit (GlobeNewswire)
Feb-15-23 04:01PM	SeaStar Medical Announces Details of the Selective Cytopheretic Device Pivotal Study in Critically ill Adults with Acute Kidney Injury (GlobeNewswire) +5.81% -5.18%
Feb-14-23 04:05PM	SeaStar Medical to Hold Business Update Conference Call on February 15, 2023 (GlobeNewswire)
Feb-09-23 08:19AM	SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury (GlobeNewswire) -15.21%
Jan-31-23 08:00AM	SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 (GlobeNewswire)
Jan-09-23 08:25AM	SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients (GlobeNewswire) +8.78%
Dec-29-22 01:35PM	SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medicals Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI) (GlobeNewswire) +9.92%
09:02AM	SeaStar Medical, Nuwellis Ink US Licensing Pact For Acute Kidney Injury Device For Pediatric Patients (Benzinga)
Dec-02-22 09:05AM	SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development (GlobeNewswire)
Nov-29-22 09:05AM	SeaStar Medical Appoints Rick Barnett as Chairman of the Board of Directors (GlobeNewswire) -9.46%
Nov-17-22 08:27AM	SeaStar Medical Holding Corporation's (NASDAQ:ICU) top owners are individual investors with 51% stake, while49% is held by institutions (Simply Wall St.) -12.68%
Nov-07-22 12:30PM	SeaStar Medicals Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting (GlobeNewswire) -10.11%
Nov-03-22 09:00AM	SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children (GlobeNewswire) -7.35%
Oct-31-22 09:25AM	SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts (GlobeNewswire) -11.90%

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chung Kevin	Chief Medical Officer	Sep 30 '24	Buy	4.26	1,000	4,258	9,435	Oct 01 04:47 PM
Van Heel Kenneth	Director	Nov 22 '23	Buy	0.40	100,000	40,000	116,400	Nov 27 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICU

SeaStar Medical Holding Corp

Upgrade your FINVIZ experience